Interleukin-18 (IL-18) is a recently identified immunoregulatory cytokine t
hat shares biochemical features with IL-1 beta and acts in part by inducing
interferon-gamma (IFN-gamma). Endotoxic bacterial lipopolysaccharide (LPS)
(1 or 2 ng/kg) was insufficient to increase plasma IL-18 in five healthy a
dults measured 3, 12, and 24 hr following challenge. In contrast, in the fi
rst 96 hr of admission to the surgical intensive carl unit, mean maximal se
rum IL-18 was elevated(1122 +/- 259 pg/ml) in nine septic patients compared
to six healthy adults (191 +/- 42, pg/ml), P < 0.01). Serum IL-18 concentr
ations in septic patients did not correlate with other measured inflammator
y mediators: tumor necrosis factor, IL-6, IL-10, or secretory leukocyte pro
tease inhibitor. Therefore, IL-18 circulates in healthy adults and is a com
ponent of the human systemic inflammatory response. Further, stimuli other
than LPS may induce IL-18 production in vivo in human sepsis.